These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 116278)

  • 1. Some effects of piracetam (UCB 6215, Nootropyl) on chronic schizophrenia.
    Dimond SJ; Scammell RE; Pryce IG; Huws D; Gray C
    Psychopharmacology (Berl); 1979 Sep; 64(3):341-8. PubMed ID: 116278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pilot study of 2-pyrrolidon-acetamid (generic name: piracetam) (author's transl)].
    Tacke B; Freistein H; Kempf H; Windheuser A
    Pharmakopsychiatr Neuropsychopharmakol; 1975 Mar; 8(2):82-9. PubMed ID: 788004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trial of 'Piracetam' in chronic schizophrenia.
    Pryce IG; Gray C
    Br J Psychiatry; 1978 Feb; 132():205. PubMed ID: 342034
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of piracetam on developmental dyslexia.
    Wilsher CR
    Int J Psychophysiol; 1986 May; 4(1):29-39. PubMed ID: 3522508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Piracetam in elderly psychiatric patients with mild diffuse cerebral impairment.
    Chouinard G; Annable L; Ross-Chouinard A; Olivier M; Fontaine F
    Psychopharmacology (Berl); 1983; 81(2):100-6. PubMed ID: 6415738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Piracetam in alcoholic psychoses: a double-blind, crossover, placebo controlled study.
    Skondia V; Kabes J
    J Int Med Res; 1985; 13(3):185-7. PubMed ID: 3891457
    [No Abstract]   [Full Text] [Related]  

  • 7. [Nootropic drugs: effects and effectiveness. A reflection exemplified by a phase III study using piracetam].
    Herrmann WM; Kern U
    Nervenarzt; 1987 Jun; 58(6):358-64. PubMed ID: 3302738
    [No Abstract]   [Full Text] [Related]  

  • 8. A double blind investigation of piracetam (Nootropil) vs placebo in geriatric memory.
    Abuzzahab FS; Merwin GE; Zimmermann RL; Sherman MC
    Pharmakopsychiatr Neuropsychopharmakol; 1977 Mar; 10(2):49-56. PubMed ID: 360232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of piracetam in vertigo. A double-blind study in patients with vertigo of central origin.
    Oosterveld WJ
    Arzneimittelforschung; 1980; 30(11):1947-9. PubMed ID: 7006617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can the pattern of neuropsychological improvement obtained with cholinergic drugs be used to infer a cholinergic mechanism in other nootropic drugs?
    Gainotti G; Nocentini U; Sena E
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13 Suppl():S47-59. PubMed ID: 2694229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double blind trial of piracetam (UCB 6215) and placebo in cases of post-ECT cognitive deficiency.
    Bagadia VN; Gada MT; Mundra VK; Simon S; Doshi JM; Pradhan PV; Shah LP; Sheth UK
    J Postgrad Med; 1980 Apr; 26(2):116-20. PubMed ID: 7012328
    [No Abstract]   [Full Text] [Related]  

  • 12. Piracetam combined with lecithin in the treatment of Alzheimer's disease.
    Growdon JH; Corkin S; Huff FJ; Rosen TJ
    Neurobiol Aging; 1986; 7(4):269-76. PubMed ID: 3528889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Piracetam in chronic brain failure.
    Lloyd-Evans S; Brocklehurst JC; Palmer MK
    Curr Med Res Opin; 1979; 6(5):351-7. PubMed ID: 540525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piracetam and dyslexia: effects on reading tests.
    Wilsher CR; Bennett D; Chase CH; Conners CK; DiIanni M; Feagans L; Hanvik LJ; Helfgott E; Koplewicz H; Overby P
    J Clin Psychopharmacol; 1987 Aug; 7(4):230-7. PubMed ID: 3305591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cognitive function in alcoholics in a double-blind study of piracetam].
    Buranji I; Skocilić Z; Kozarić-Kovacić D
    Lijec Vjesn; 1990; 112(3-4):111-4. PubMed ID: 2204773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of alcohol organic mental disorder with piracetam.
    Barnas C; Miller C; Gunther V; Fleischhacker WW
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(6):729-37. PubMed ID: 3326044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effectiveness of piracetam in tardive dyskinesia - double-blind cross-over controlled trial with a placebo].
    Kabes J; Sikora J; Starý O; Pisvejc J; Hanzlícek L
    Cesk Psychiatr; 1983 Oct; 79(5):339-45. PubMed ID: 6357509
    [No Abstract]   [Full Text] [Related]  

  • 18. A double-blind investigation of piracetam (nootropil) versus placebo in the memory of geriatric inpatients.
    Abuzzahab FS; Merwin GE; Zimmermann RL; Sherman MC
    Psychopharmacol Bull; 1978 Jan; 14(1):23-5. PubMed ID: 343146
    [No Abstract]   [Full Text] [Related]  

  • 19. A double-blind, placebo-controlled study of piracetam in elderly psychiatric patients [proceedings].
    Chouinard G; Annable L; Ross-Chouinard A; Olivier M; Fontaine F
    Psychopharmacol Bull; 1981 Jan; 17(1):129. PubMed ID: 7232645
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of piracetam in Huntington's chorea.
    Destée A; Petit H; Warot P
    Eur Neurol; 1984; 23(2):89-91. PubMed ID: 6233148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.